Showing results (21-30 of 1,607) with videos related to
Sort By:
Pageof 161
JAMA Oncology|January 13, 2022
Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in EligibilityChan Yeu Pu, Christine M Lusk, Christine Neslund-Dudas, et al.JAMA Oncology|January 20, 2022
Evidence-Based Clinical Practice Guidelines for Extramammary Paget DiseaseNour Kibbi, Joshua L Owen, Brandon Worley, et al.JAMA Oncology|February 15, 2019
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical TrialDeborah W Bruner, Stephanie L Pugh, W Robert Lee, et al.JAMA Oncology|June 28, 2019
Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer: A Randomized, Open-label Phase 2 StudyGerhardt Attard, Axel S Merseburger, Wiebke Arlt, et al.JAMA Oncology|June 28, 2019
Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult SmokersMelinda C Aldrich, Sarah F Mercaldo, Kim L Sandler, et al.JAMA Oncology|June 14, 2019
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical TrialBarbara Burtness, Robert Haddad, José Dinis, et al.JAMA Oncology|May 31, 2019
Assessment of Subcutaneous vs Intravenous Administration of Anti-PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors: A Phase 1 Dose-Escalation TrialMelissa L Johnson, Fadi Braiteh, Juneko E Grilley-Olson, et al.JAMA Oncology|May 31, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical TrialJanet E Murphy, Jennifer Y Wo, David P Ryan, et al.JAMA Oncology|April 28, 2022
Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical TrialDavid A Palma, Eitan Prisman, Eric Berthelet, et al.Pageof 161